My practice

Therapy for depression, anxiety, trauma, PTSD, bipolar disorder and schizophrenia. Specializing in a narrow range of problems allows me to keep current on multiple ways of treating each problem.

I’m part of Clarity Clinic in Chicago, IL, at the Loop office. We have therapists with a lot of different specialties. Mine is mental illness, including depression, anxiety, bipolar disorder, schizophrenia, and trauma.

A lot of therapists only use one type of treatment. They only do neurofeedback, or only cognitive-behavioral therapy, and they apply it to a lot of different types of problems. There’s nothing wrong with that, but for people with serious mental illness, that can result in a lot of therapist-hopping when that one type of treatment doesn’t work for you. Instead, I can offer several options for treatment, and we’ll decide together which one we should try. If that one doesn’t work after a while, we’ll try something different or create a custom mix based on your individual needs.

I’m experienced in cognitive-behavioral therapy, accceptance and commitment therapy, dialectical behavior therapy, and Adlerian therapy, and often integrate techniques from other styles when it matches the needs of a client. In this way, clients can get therapy that is both evidence-based and customized, and they have a voice in their treatment. Every style of therapy has a set of values behind it, and that can also affect the treatment we choose.

I’m also competent in some techniques that are specific to certain disorders, such as interpersonal and social rhythm therapy for bipolar disorder.

I welcome clients of every race, sexual and gender orientation, and disability status. People with neurodevelopmental disorders such as autism or ADD/ADHD are welcome here, as are people with physical and intellectual disabilities.

Aimee Daramus, Psy.D., licensed clinical psychologist.

I got my first job in the mental health field in 1997, during my junior year of college. I’ve had experience at every level in the continuity of care, from the psychiatric unit to day programs and IOPs, to people coping with depression, anxiety, or voices (for example) while they’re working and raising a family.

I’ve been a part-time professor at Harold Washington College for fifteen years, and have also taught classes at Wright College, Truman College snd Adler University. For fun, I volunteer at the Glessner House Museum. 

As service to the community, I give free or low-cost presentations on suicide prevention, PTSD prevention after a trauma, and other aspects of mental health emergency management. I also offer a free one hour talk on how to select a therapist and check their credentials.

Scroll to Top

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At AudeoTherapy, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.